20.05.2015 • News

Dow Opposes Louisiana’s “Religious Freedom” Bill

Dow Chemical has spoken out in strong opposition to the US state of Louisana's plans for a religious freedom act that would allow companies to refuse to do business with legally married same-sex couples on religious grounds.

The bill, similar to initiatives launched by religious conservatives in other US states, was introduced by state representative Mike Johnson. It is currently being debated in the state House of Representatives and has received support from Louisiana Governor Bobby Jindal.

Dow said it opposes bill 707 as well as "any similar efforts to hinder our ability to recruit talent to our growing Louisiana operations. We call upon our legislative leaders to focus on making our state more competitive and economically sound instead of taking actions that divide our citizens," Earl Shipp, vice president of Dow Gulf Coast operations, said in a written statement.

"Inclusion of our LGBT colleagues is a matter of fairness and equality," said Shipp. "It is also a business imperative. And as we expand our operations throughout the Gulf Coast region, creating thousands of jobs, we urge the Legislature to help us foster that same sense of fairness and inclusion."

Dow is believed to be the first chemical producer to speak out against the Louisiana bill. IBM said earlier it also had strong reservations against the proposed legislation.

With 6,000 employees at five Louisiana locations, Dow is the state's largest chemical employer.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.